Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells.
Epperly R, Giordani VM, Mikkilineni L, Shah NN. Epperly R, et al. Among authors: shah nn. Hematol Oncol Clin North Am. 2023 Dec;37(6):1169-1188. doi: 10.1016/j.hoc.2023.05.010. Epub 2023 Jun 21. Hematol Oncol Clin North Am. 2023. PMID: 37349152 Review.
Improving CAR T-cells: The next generation.
Marple AH, Bonifant CL, Shah NN. Marple AH, et al. Among authors: shah nn. Semin Hematol. 2020 Jul;57(3):115-121. doi: 10.1053/j.seminhematol.2020.07.002. Epub 2020 Jul 23. Semin Hematol. 2020. PMID: 33256900 Review.
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cells.
Shalabi H, Gust J, Taraseviciute A, Wolters PL, Leahy AB, Sandi C, Laetsch TW, Wiener L, Gardner RA, Nussenblatt V, Hill JA, Curran KJ, Olson TS, Annesley C, Wang HW, Khan J, Pasquini MC, Duncan CN, Grupp SA, Pulsipher MA, Shah NN. Shalabi H, et al. Among authors: shah nn. Nat Rev Clin Oncol. 2021 Jun;18(6):363-378. doi: 10.1038/s41571-020-00456-y. Epub 2021 Jan 25. Nat Rev Clin Oncol. 2021. PMID: 33495553 Free PMC article. Review.
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days.
Mikkilineni L, Yates B, Steinberg SM, Shahani SA, Molina JC, Palmore T, Lee DW, Kaplan RN, Mackall CL, Fry TJ, Gea-Banacloche J, Jerussi T, Nussenblatt V, Kochenderfer JN, Shah NN. Mikkilineni L, et al. Among authors: shah nn. Blood Adv. 2021 Dec 14;5(23):5312-5322. doi: 10.1182/bloodadvances.2021004896. Blood Adv. 2021. PMID: 34619768 Free PMC article. Review.
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes.
Faruqi AJ, Ligon JA, Borgman P, Steinberg SM, Foley T, Little L, Mackall CL, Lee DW, Fry TJ, Shalabi H, Brudno J, Yates B, Mikkilineni L, Kochenderfer J, Shah NN. Faruqi AJ, et al. Among authors: shah nn. Blood Adv. 2022 Dec 13;6(23):6040-6050. doi: 10.1182/bloodadvances.2022007676. Blood Adv. 2022. PMID: 35939781 Free PMC article.
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics.
Prochazkova M, Dreyzin A, Shao L, Garces P, Cai Y, Shi R, Pelayo A, Kim YS, Pham V, Frodigh SE, Fenton S, Karangwa C, Su Y, Martin K, Zhang N, Highfill SL, Somerville RP, Shah NN, Stroncek DF, Jin P. Prochazkova M, et al. Among authors: shah nn. J Transl Med. 2024 Apr 24;22(1):384. doi: 10.1186/s12967-024-05197-5. J Transl Med. 2024. PMID: 38659083 Free PMC article.
431 results